Louie Ngar Yee 4
4 · MAIA Biotechnology, Inc. · Filed Apr 26, 2024
Insider Transaction Report
Form 4
Louie Ngar Yee
Director
Transactions
- Purchase
Common Stock
2024-04-25$2.03/sh+19,665$39,920→ 1,167,189 total - Purchase
Warrants
2024-04-25$2.26/sh+19,665$44,443→ 19,665 totalExercise: $2.26From: 2024-10-25Exp: 2029-10-25→ Common Stock (19,665 underlying)
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024.
- [F2]The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.